Connect Biopharma Holdings (CNTB) Receivables - Other (2020 - 2026)

Connect Biopharma Holdings has disclosed Receivables - Other across 7 years of filings, most recently posting $22000.0 for Q2 2026.

• In Q2 2026, Receivables - Other fell 88.6% year-over-year to $22000.0; the TTM figure through Jun 2026 stood at $22000.0 (down 88.6% YoY), while the FY2025 annual figure was $148000.0, down 43.51% from the prior year.
• Receivables - Other came in at $22000.0 for Q2 2026 at Connect Biopharma Holdings, down from $32000.0 in the prior quarter.
• In the past five years, Receivables - Other ranged from a high of $3.2 million in Q2 2023 to a low of $22000.0 in Q2 2026.
• Average Receivables - Other over 5 years is $473926.8, with a median of $193000.0 recorded in 2025.
• Year-over-year, Receivables - Other soared 629.47% in 2023 and sank 88.6% in 2026.
• Over 5 years, Receivables - Other stood at $227075.6 in 2022, then soared by 54.57% to $351000.0 in 2023, then fell by 25.36% to $262000.0 in 2024, then sank by 43.51% to $148000.0 in 2025, then tumbled by 85.14% to $22000.0 in 2026.
• Per Business Quant data, the three most recent Receivables - Other figures were $22000.0 in Q2 2026, $32000.0 in Q1 2026, and $148000.0 in Q4 2025.